Surgimate, a leader in surgical coordination and scheduling software, has announced the appointment of Alisa Vaughn as its Chief Operating Officer. Vaughn will focus on aligning and improving the customer experience across Surgimate's various business lines, including surgical scheduling, medical device coordination, and patient access. Her collaboration with CEO Kraig Brown aims to scale initiatives that foster strategic growth.
This appointment matters because it signals Surgimate's commitment to operational excellence and customer-centric innovation in the complex surgical ecosystem. With over 750,000 surgical events facilitated in 2024 across more than 100 practices, Surgimate is already a significant player. Vaughn's expertise in healthcare operations and leadership is expected to drive the company's next phase of growth, potentially improving efficiency and outcomes for care teams and patients across the New York metro area and beyond.
Vaughn brings over 15 years of experience, including executive positions at Trusted Doctors and Office Practicum. Her background in mergers and acquisitions, organizational design, and infrastructure strategy will be instrumental in creating long-term value. By focusing on the customer journey, Vaughn aims to solve complex problems and deliver impactful results, potentially setting new standards in surgical care delivery.
For the New York City metro area, where healthcare innovation is critical, Surgimate's growth has direct implications. The company's software enhances surgical project management, reporting, and form generation, which can reduce administrative burdens and improve patient access. As Surgimate scales under Vaughn's operational leadership, local hospitals and practices may benefit from more streamlined coordination, ultimately leading to better patient outcomes and reduced costs.
Vaughn's appointment also reflects broader trends in healthcare technology, where companies are increasingly focusing on integrated solutions to address fragmented workflows. Surgimate's ability to connect surgical scheduling, device coordination, and patient access under a unified customer experience strategy could serve as a model for other health tech firms. The company's dual headquarters in New York and R&D offices in Israel position it to leverage diverse talent and global insights, further enhancing its competitive edge.
